Concordance for clonal hematopoiesis is limited in elderly twins.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
23 01 2020
Historique:
received: 28 05 2019
accepted: 06 10 2019
pubmed: 8 11 2019
medline: 1 7 2020
entrez: 8 11 2019
Statut: ppublish

Résumé

Although acquisition of leukemia-associated somatic mutations by 1 or more hematopoietic stem cells is inevitable with advancing age, its consequences are highly variable, ranging from clinically silent clonal hematopoiesis (CH) to leukemic progression. To investigate the influence of heritable factors on CH, we performed deep targeted sequencing of blood DNA from 52 monozygotic (MZ) and 27 dizygotic (DZ) twin pairs (aged 70-99 years). Using this highly sensitive approach, we identified CH (variant allele frequency ≥0.5%) in 62% of individuals. We did not observe higher concordance for CH within MZ twin pairs as compared with that within DZ twin pairs, or to that expected by chance. However, we did identify 2 MZ pairs in which both twins harbored identical rare somatic mutations, suggesting a shared cell of origin. Finally, in 3 MZ twin pairs harboring mutations in the same driver genes, serial blood samples taken 4 to 5 years apart showed substantial twin-to-twin variability in clonal trajectories. Our findings propose that the inherited genome does not exert a dominant influence on the behavior of adult CH and provide evidence that CH mutations may be acquired in utero.

Identifiants

pubmed: 31697828
pii: S0006-4971(20)62289-3
doi: 10.1182/blood.2019001807
pmc: PMC6978156
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

269-273

Subventions

Organisme : Medical Research Council
ID : MC_PC_12009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R023131/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M004422/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C22324/A23015
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/14/5/30893
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT098051
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 by The American Society of Hematology.

Références

Evol Med Public Health. 2018 Apr 14;2018(1):106-115
pubmed: 29765597
Nat Genet. 2018 Jun;50(6):883-894
pubmed: 29736013
Cell. 2016 Nov 17;167(5):1415-1429.e19
pubmed: 27863252
Bioinformatics. 2014 May 1;30(9):1198-204
pubmed: 24443148
Nature. 2017 Mar 30;543(7647):714-718
pubmed: 28329761
Int J Epidemiol. 2013 Feb;42(1):76-85
pubmed: 22253318
N Engl J Med. 2013 Dec 19;369(25):2391-2405
pubmed: 24325359
Nature. 2018 Sep;561(7724):473-478
pubmed: 30185910
Leukemia. 2014 Feb;28(2):241-7
pubmed: 24220272
Blood. 2013 Nov 21;122(22):3616-27; quiz 3699
pubmed: 24030381
Cell Rep. 2015 Mar 3;10(8):1239-45
pubmed: 25732814
Nat Genet. 2009 Apr;41(4):446-9
pubmed: 19287382
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Blood. 2016 Aug 25;128(8):1121-8
pubmed: 27365426
N Engl J Med. 2014 Dec 25;371(26):2477-87
pubmed: 25426838
Blood Adv. 2017 Jun 12;1(14):968-971
pubmed: 29296738
J Clin Oncol. 2019 Feb 10;37(5):375-385
pubmed: 30403573
Nat Commun. 2016 Aug 22;7:12484
pubmed: 27546487
Nature. 2018 May;557(7706):580-584
pubmed: 29769727
Psychometrika. 2016 Jun;81(2):535-49
pubmed: 25622929
Science. 2015 May 22;348(6237):880-6
pubmed: 25999502
Nat Med. 2014 Dec;20(12):1472-8
pubmed: 25326804
Nature. 2019 Jan;565(7739):312-317
pubmed: 30602793
Blood. 2017 Aug 10;130(6):753-762
pubmed: 28655780
Nature. 2018 Jul;559(7714):400-404
pubmed: 29988082

Auteurs

Margarete A Fabre (MA)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Wellcome-Medical Research Council (MRC) Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Department of Haematology, Cambridge University Hospitals National Health Service (NHS) Trust, Cambridge, United Kingdom.

Thomas McKerrell (T)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Wellcome-Medical Research Council (MRC) Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Department of Haematology, Cambridge University Hospitals National Health Service (NHS) Trust, Cambridge, United Kingdom.

Maximillian Zwiebel (M)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
German Consortium for Translational Cancer Research (DKTK), Partnering Site Munich, Munich, Germany.

M S Vijayabaskar (MS)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Wellcome-Medical Research Council (MRC) Cambridge Stem Cell Institute, Cambridge, United Kingdom.

Naomi Park (N)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.

Philippa M Wells (PM)

Department of Twin Research and Genetic Epidemiology, School of Life Course Sciences, King's College London, London, United Kingdom; and.

Roland Rad (R)

German Consortium for Translational Cancer Research (DKTK), Partnering Site Munich, Munich, Germany.

Panagiotis Deloukas (P)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

Kerrin Small (K)

Department of Twin Research and Genetic Epidemiology, School of Life Course Sciences, King's College London, London, United Kingdom; and.

Claire J Steves (CJ)

Department of Twin Research and Genetic Epidemiology, School of Life Course Sciences, King's College London, London, United Kingdom; and.

George S Vassiliou (GS)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Wellcome-Medical Research Council (MRC) Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Department of Haematology, Cambridge University Hospitals National Health Service (NHS) Trust, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH